Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY15.34 CNY
Change Today +0.84 / 5.79%
Volume 60.8M
000650 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

renhe pharmacy co ltd-a (000650) Snapshot

Open
CNY14.52
Previous Close
CNY14.50
Day High
CNY15.47
Day Low
CNY14.30
52 Week High
05/22/15 - CNY15.47
52 Week Low
06/24/14 - CNY4.58
Market Cap
15.2B
Average Volume 10 Days
49.6M
EPS TTM
CNY0.33
Shares Outstanding
990.7M
EX-Date
05/26/15
P/E TM
47.2x
Dividend
CNY0.03
Dividend Yield
0.65%
Current Stock Chart for RENHE PHARMACY CO LTD-A (000650)

Related News

No related news articles were found.

renhe pharmacy co ltd-a (000650) Related Businessweek News

No Related Businessweek News Found

renhe pharmacy co ltd-a (000650) Details

Renhe Pharmacy Co., Ltd operates in the pharmaceutical industry in China. The company produces and sells medicine, bulk drugs, and health-related products, including oral solid dosage, oral liquid preparations, injections, topical lotions, liniments, suppositories, and ointments, as well as other forms of drugs. It is also engaged in the wholesale and retail of related pharmaceuticals and healthcare products. The company’s principal products include Compound Paracetamol and Amantadine Hydrochloride capsules, which are used to treat common cold; Miconazole Nitrate cream that is used to cure skin disease and gynopathy; and Pediatric Paracetamol and Amantadine Hydrochloride granules, which are used for the prevention and treatment of children's influenza. Renhe Pharmacy Co., Ltd is based in Beijing, China.

renhe pharmacy co ltd-a (000650) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

renhe pharmacy co ltd-a (000650) Key Developments

Renhe Pharmacy Co., Ltd(SZSE:000650) added to Shenzhen Stock Exchange Component A Share Index

Renhe Pharmacy Co., Ltd has been added to Shenzhen Stock Exchange Component A Share Index.

Renhe Pharmacy Co., Ltd(SZSE:000650) added to Shenzhen Stock Exchange Component Index

Renhe Pharmacy Co., Ltd has been added to Shenzhen Stock Exchange Component Index.

Renhe Pharmacy Co., Ltd Announces Profit Distribution for 2014, Payable on May 26, 2015

Renhe Pharmacy Co. Ltd. announced profit distribution plan for 2014 of CNY 0.30000000 per 10 shares (tax included), payable on May 26, 2015. Record date is May 25, 2015 and Ex-date is May 26, 2015. Net amount after tax per 10 shares was CNY 0.02000000.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000650:CH CNY15.34 CNY +0.84

000650 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000650.
View Industry Companies
 

Industry Analysis

000650

Industry Average

Valuation 000650 Industry Range
Price/Earnings 47.8x
Price/Sales 6.5x
Price/Book 7.2x
Price/Cash Flow 47.2x
TEV/Sales 6.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RENHE PHARMACY CO LTD-A, please visit www.renheyaoye.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.